Novartis Investigative Site

Morioka, Iwate 020-8505

0 studies enrolling now · 2 studies all time

What they study most

Heart Failure With Preserved Ejection Fraction, Secondary Progressive Multiple Sclerosis

Studies at this site

• Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) — Completed
• Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed